Key points are not available for this paper at this time.
The survival benefit of sentinel lymph node biopsy (SLNB) in immunocompetent and immunosuppressed patients with high-risk cutaneous squamous cell carcinoma (cSCC) has not been established.
Tejera‐Vaquerizo et al. (Mon,) studied this question.